Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, placebo-controlled phase 3 trial.
Yan K, Li F, Bi X, Han L, Zhang Z, Chen R, Li Y, Zhang L, Wang X, Li L, Lu J, Xu A, Yang S, Lu Y, Sun J, Li Z, Zhu X, Jiang M, Zhang S, Wang W, Li Y, Meng Z, Li H, Mou K, Han X, Li S, Chen A, Li X, Liu D, Zhang C, Ji C, Wang Y, Cheng H, Cui X, Yao X, Bai X, Dong G, Xu J.
Yan K, et al. Among authors: li f.
J Am Acad Dermatol. 2024 Sep 25:S0190-9622(24)02887-1. doi: 10.1016/j.jaad.2024.09.031. Online ahead of print.
J Am Acad Dermatol. 2024.
PMID: 39332633